Annual EBITDA
-$80.27 M
+$42.50 M+34.62%
December 31, 2023
Summary
- As of March 12, 2025, PYXS annual EBITDA is -$80.27 million, with the most recent change of +$42.50 million (+34.62%) on December 31, 2023.
- During the last 3 years, PYXS annual EBITDA has fallen by -$67.84 million (-546.03%).
- PYXS annual EBITDA is now -2688.09% below its all-time high of -$2.88 million, reached on December 31, 2019.
Performance
PYXS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$23.02 M
-$3.58 M-18.39%
September 30, 2024
Summary
- As of March 12, 2025, PYXS quarterly EBITDA is -$23.02 million, with the most recent change of -$3.58 million (-18.39%) on September 30, 2024.
- Over the past year, PYXS quarterly EBITDA has increased by +$1.81 million (+7.28%).
- PYXS quarterly EBITDA is now -687.65% below its all-time high of -$2.92 million, reached on September 30, 2020.
Performance
PYXS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$64.04 M
+$1.81 M+2.75%
September 30, 2024
Summary
- As of March 12, 2025, PYXS TTM EBITDA is -$64.04 million, with the most recent change of +$1.81 million (+2.75%) on September 30, 2024.
- Over the past year, PYXS TTM EBITDA has increased by +$36.94 million (+36.58%).
- PYXS TTM EBITDA is now -2090.76% below its all-time high of -$2.92 million, reached on September 30, 2020.
Performance
PYXS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PYXS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.6% | +7.3% | +36.6% |
| 3 y3 years | -546.0% | -30.8% | +38.6% |
| 5 y5 years | -2688.1% | -30.8% | +38.6% |
PYXS EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -16.2% | +34.6% | -412.9% | +39.1% | -0.1% | +47.8% |
| 5 y | 5-year | -2688.1% | +34.6% | -687.6% | +39.1% | -2090.8% | +47.8% |
| alltime | all time | -2688.1% | +34.6% | -687.6% | +39.1% | -2090.8% | +47.8% |
Pyxis Oncology EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$23.02 M(+18.4%) | -$64.04 M(-2.7%) |
| Jun 2024 | - | -$19.45 M(+333.2%) | -$65.84 M(+2.9%) |
| Mar 2024 | - | -$4.49 M(-73.7%) | -$63.99 M(-20.3%) |
| Dec 2023 | -$80.27 M(-34.6%) | -$17.08 M(-31.2%) | -$80.27 M(-20.5%) |
| Sep 2023 | - | -$24.83 M(+41.1%) | -$100.97 M(-3.2%) |
| Jun 2023 | - | -$17.60 M(-15.3%) | -$104.33 M(-7.1%) |
| Mar 2023 | - | -$20.76 M(-45.0%) | -$112.31 M(-8.5%) |
| Dec 2022 | -$122.77 M | -$37.78 M(+34.0%) | -$122.77 M(+21.2%) |
| Sep 2022 | - | -$28.19 M(+10.3%) | -$101.26 M(+19.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$25.57 M(-18.1%) | -$84.53 M(+30.7%) |
| Mar 2022 | - | -$31.23 M(+92.0%) | -$64.69 M(-6.3%) |
| Dec 2021 | -$69.07 M(+455.9%) | -$16.27 M(+41.9%) | -$69.07 M(+20.7%) |
| Sep 2021 | - | -$11.46 M(+100.2%) | -$57.21 M(+17.5%) |
| Jun 2021 | - | -$5.72 M(-83.9%) | -$48.67 M(+13.3%) |
| Mar 2021 | - | -$35.62 M(+707.8%) | -$42.95 M(+485.8%) |
| Dec 2020 | -$12.43 M(+331.6%) | -$4.41 M(+50.8%) | -$7.33 M(+150.8%) |
| Sep 2020 | - | -$2.92 M | -$2.92 M |
| Dec 2019 | -$2.88 M | - | - |
FAQ
- What is Pyxis Oncology annual EBITDA?
- What is the all time high annual EBITDA for Pyxis Oncology?
- What is Pyxis Oncology annual EBITDA year-on-year change?
- What is Pyxis Oncology quarterly EBITDA?
- What is the all time high quarterly EBITDA for Pyxis Oncology?
- What is Pyxis Oncology quarterly EBITDA year-on-year change?
- What is Pyxis Oncology TTM EBITDA?
- What is the all time high TTM EBITDA for Pyxis Oncology?
- What is Pyxis Oncology TTM EBITDA year-on-year change?
What is Pyxis Oncology annual EBITDA?
The current annual EBITDA of PYXS is -$80.27 M
What is the all time high annual EBITDA for Pyxis Oncology?
Pyxis Oncology all-time high annual EBITDA is -$2.88 M
What is Pyxis Oncology annual EBITDA year-on-year change?
Over the past year, PYXS annual EBITDA has changed by +$42.50 M (+34.62%)
What is Pyxis Oncology quarterly EBITDA?
The current quarterly EBITDA of PYXS is -$23.02 M
What is the all time high quarterly EBITDA for Pyxis Oncology?
Pyxis Oncology all-time high quarterly EBITDA is -$2.92 M
What is Pyxis Oncology quarterly EBITDA year-on-year change?
Over the past year, PYXS quarterly EBITDA has changed by +$1.81 M (+7.28%)
What is Pyxis Oncology TTM EBITDA?
The current TTM EBITDA of PYXS is -$64.04 M
What is the all time high TTM EBITDA for Pyxis Oncology?
Pyxis Oncology all-time high TTM EBITDA is -$2.92 M
What is Pyxis Oncology TTM EBITDA year-on-year change?
Over the past year, PYXS TTM EBITDA has changed by +$36.94 M (+36.58%)